Pierre Gantner
Overview
Explore the profile of Pierre Gantner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1749
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitchell J, Buranapraditkun S, Gantner P, Takata H, Dietze K, Nguessan K, et al.
J Virol
. 2025 Feb;
:e0153224.
PMID: 39932316
Importance: Early initiation of antiretroviral therapy (ART) is important to limit the seeding of the long-lasting HIV-1 reservoir; however, it also precludes the development of HIV-specific antibodies that can help...
2.
Wirden M, Tombette F, Lambert-Niclot S, Chaix M, Marque-Juillet S, Bouvier-Alias M, et al.
J Int AIDS Soc
. 2025 Jan;
28(2):e26416.
PMID: 39875664
Introduction: Molecular surveillance is an important tool for detecting chains of transmission and controlling the HIV epidemic. This can also improve our knowledge of molecular and epidemiological factors for the...
3.
Parfut A, Glady L, Gonzalez G, Wendling M, Pierson A, Ertle A, et al.
J Neurovirol
. 2024 Oct;
30(5-6):534-544.
PMID: 39480620
Tick-borne encephalitis (TBE) is a vector-borne disease caused by the TBE virus (TBEV). Although TBEV infection in children seems to lead to a milder clinical presentation, data in pediatrics are...
4.
Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines
Lin L, Gantner P, Li S, Su B, Moog C
J Infect Dis
. 2024 Sep;
231(1):e1-e9.
PMID: 39302695
Developing effective vaccines is necessary in combating new virus pandemics. For human immunodeficiency virus (HIV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the induction of neutralizing antibodies (NAb) is...
5.
Parfut A, Gantner P, Hoellinger B, Ferreira L, Biry M, Hansmann Y, et al.
Infect Dis Now
. 2024 Jul;
54(7):104956.
PMID: 39043249
Background: Vector-borne diseases such as malaria and arboviruses are common etiologies of post-travel fever. Methods: After excluding malaria, we retrospectively analyzed the diagnosis of dengue virus (DENV), chikungunya virus (CHIKV),...
6.
Mesplede T, Gantner P
Clin Infect Dis
. 2024 Mar;
79(6):1541-1542.
PMID: 38462992
No abstract available.
7.
Faua C, Ursenbach A, Fuchs A, Caspar S, Jegou F, Ruch Y, et al.
Pathog Immun
. 2024 Feb;
8(2):92-114.
PMID: 38420260
Background: Throughout HIV infection, productively infected cells generate billions of viral particles and are thus responsible for body-wide HIV dissemination, but their phenotype during AIDS is unknown. As AIDS is...
8.
Parfut A, Tripon S, Gantner P, Chaffraix F, Laugel E, Wendling M, et al.
J Clin Virol
. 2024 Feb;
171:105650.
PMID: 38350177
Background: Hepatitis Delta virus (HDV) infection is a major cause of liver-related morbidity and mortality in patients infected with HBV, with a global HDV prevalence uncertain. In France, 2 to...
9.
Ursenbach A, Ruch Y, Hoellinger B, Fuchs A, Caspar S, Jegou F, et al.
Clin Infect Dis
. 2024 Jan;
79(1):198-201.
PMID: 38193816
Dolutegravir/lamivudine (DTG/3TC) has a high genetic barrier against the development of human immunodeficiency virus drug resistance. We report 2 cases of R263K + M184V mutations during DTG/3TC failure followed by...
10.
Comparison of HIV-1 DNA load measurements in blood and in relation to successful proviral sequencing
Fuchs A, Wasser A, Faua C, Caspar S, Jegou F, Velay A, et al.
Infect Dis Now
. 2023 Dec;
54(2):104845.
PMID: 38103598
Objective: HIV DNA sequencing is now routinely used for HIV-infected individuals on antiretroviral therapy (ART) with or without partial genotypic history. Successful amplification of HIV pol gene has yet to...